Pink, D.; Andreou, D.; Bauer, S.; Brodowicz, T.; Kasper, B.; Reichardt, P.; Richter, S.; Lindner, L.H.; Szkandera, J.; Grünwald, V.;
et al. Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06). Cancers 2021, 13, 1223.
https://doi.org/10.3390/cancers13061223
AMA Style
Pink D, Andreou D, Bauer S, Brodowicz T, Kasper B, Reichardt P, Richter S, Lindner LH, Szkandera J, Grünwald V,
et al. Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06). Cancers. 2021; 13(6):1223.
https://doi.org/10.3390/cancers13061223
Chicago/Turabian Style
Pink, Daniel, Dimosthenis Andreou, Sebastian Bauer, Thomas Brodowicz, Bernd Kasper, Peter Reichardt, Stephan Richter, Lars H. Lindner, Joanna Szkandera, Viktor Grünwald,
and et al. 2021. "Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)" Cancers 13, no. 6: 1223.
https://doi.org/10.3390/cancers13061223
APA Style
Pink, D., Andreou, D., Bauer, S., Brodowicz, T., Kasper, B., Reichardt, P., Richter, S., Lindner, L. H., Szkandera, J., Grünwald, V., Kebenko, M., Kirchner, M., & Hohenberger, P.
(2021). Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06). Cancers, 13(6), 1223.
https://doi.org/10.3390/cancers13061223